Endometrial cancer and the IGF system: A case-control study in Greece

Oncology

Volumn 64, Issue 4, 2003, Pages 341-345

  Petridou, Eleni ^a,b   Koukoulomatis, Panagiotis ^a   Alexe, Delia Marina ^a   Voulgaris, Zannis ^a   Spanos, Evagelos ^c   Trichopoulos, Dimitrios ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Biomed International Diagnostic Center   (Greece)

Author keywords

Endometrial cancer; IGF factors; Obesity

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN B; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; ENDOMETRIUM CARCINOMA; FEMALE; GREECE; GYNECOLOGIC SURGERY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PRIORITY JOURNAL; UTERUS PROLAPSE; BLOOD; ENDOMETRIUM TUMOR; METABOLISM; MIDDLE AGED; STATISTICAL MODEL;

AGED; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; GREECE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LOGISTIC MODELS; MIDDLE AGED;

EID: 0038651242     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070291     Document Type: Article

References (21)

1. Cohen P: Serum insulin-like growth factor-I levels and prostate cancer risk-interpreting the evidence. J Natl Cancer Inst 1998;90:876-879.
2. Wolk A, Mantzoros CS, Andersson SO, Bergstrom R, Signorello LB, Lagiou P, Adami HO, Trichopoulos D: Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study. J Natl Cancer Inst 1998;90:911-915.
3. Pollak M, Beamer W, Zhang JC: Insulin-like growth factors and prostate cancer. Cancer Metastasis Rev 1998-99;17:383-390.
4. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-1396.
5. Manousos O, Souglakos J, Bosetti C, Tzonou A, Chatziadakis V, Trichopoulos D, Adami HO, Mantzoros C: IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer 1999;83:15-17.
6. Petridou E, Dessypris N, Spanos E, Mantzoros C, Skalkidou A, Kalmanti M, Koliouskas D, Kosmidis H, Panagiotou JP, Piperopoulou F, Tzortzatou F, Trichopoulos D: Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia. Int J Cancer 1999;80:494-496.
7. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X: Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis. J Natl Cancer Inst 1999;91:151-156.
8. Mathur SP, Mathur RS, Young RC: Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer. Am J Reprod Immunol 2000;44:222-230.
9. Bermont L, Fauconnet S, Lamielle F, Adessi GL: Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation. Cell Mol Biol (Noisy-le-Grand) 2000;46:1173-1182.
10. Roy RN, Gerulath AH, Cecutti A, Bhavnani BR: Loss of IGF-II imprinting in endometrial tumors: Overexpression in carcinosarcoma. Cancer Lett 2000;153:67-73.
11. Rutanen EM, Stenman S, Blum W, Karkkainen T, Lehtovirta P, Stenman UH: Relationship between carbohydrate metabolism and serum insulin-like growth factor system in post-menopausal women: Comparison of endometrial cancer patients with healthy controls. J Clin Endocrinol Metab 1993;77:199-204.
12. Ayabe T, Tsutsumi O, Sakai H, Yoshikawa H, Yano T, Kurimoto F, Taketani Y: Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer. Endocr J 1997;44:419-424.
13. Bosetti C, Negri E, Franceschi S, Trichopoulos D, Beral V, La Vecchia C: Relationship between postmenopausal hormone replacement therapy and ovarian cancer. JAMA 2001;285:3089-3090.
14. Petridou E, Koukoulomatis P, Dessypris N, Karalis D, Mihalas S, Trichopoulos D: Why is endometrial cancer less common in Greece than in other European Union countries? Eur J Cancer Prev, in press.
15. Parazzini F, La Vecchia C, Negri E, Riboldi GL, Surace M, Benzi G, Maina A, Chiaffarino F: Diabetes and endometrial cancer: An Italian case-control study. Int J Cancer 1999;81:539-542.
16. Sherman ME: Theories of endometrial carcinogenesis: A multidisciplinary approach. Mod Pathol 2000;13:295-308.
17. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA: Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000;11:185-192.
18. Rutanen EM, Nyman T, Lehtovirta P, Ammala M, Pekonen F: Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: A molecular mechanism associating endometrial cancer with its risk factors. Int J Cancer 1994;59:307-312.
19. Giovannucci E: Insulin-like growth factor-I and binding protein-3 and risk of cancer. Horm Res 1999;51(suppl 3):34-41.
20. Suga K, Imai K, Eguchi H, Hayashi S, Higashi Y, Nakachi K: Molecular significance of excess body weight in postmenopausal breast cancer patients, in relation to expression of insulin-like growth factor I receptor and insulin-like growth factor II genes. Jpn J Cancer Res 2001;92:127-134.
21. La Vecchia C, Franceschi S, Decarli A, Gallus G, Tognoni G: Risk factors for endometrial cancer at different ages. J Natl Cancer Inst 1984;73:667-671.